Jane Street
ALXN

Jane Street’s Alexion Pharmaceuticals ALXN Stock Holding History

Jane Street’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-77,200
Closed -$14.2M – 11266
2021
Q2 		$14.2M Buy
77,200
+20,400
+36% +$3.5M 0.01% 1368
2021
Q1 		$8.69M Sell
56,800
-271,400
-83% -$42M ﹤0.01% 1695
2020
Q4 		$51.3M Buy
328,200
+117,000
+55% +$15M 0.03% 448
2020
Q3 		$24.2M Buy
211,200
+14,700
+7% +$1.59M 0.01% 673
2020
Q2 		$22.1M Buy
196,500
+82,300
+72% +$8.74M 0.02% 699
2020
Q1 		$10.3M Buy
114,200
+45,500
+66% +$4.47M 0.01% 756
2019
Q4 		$7.43M Buy
68,700
+31,400
+84% +$3.36M 0.01% 810
2019
Q3 		$3.65M Sell
37,300
-23,200
-38% -$2.62M 0.01% 1239
2019
Q2 		$7.92M Sell
60,500
-8,800
-13% -$1.13M 0.01% 751
2019
Q1 		$9.37M Buy
69,300
+25,200
+57% +$3.13M 0.02% 727
2018
Q4 		$4.29M Buy
44,100
+3,600
+9% +$426K 0.01% 1042
2018
Q3 		$5.63M Sell
40,500
-2,700
-6% -$339K 0.01% 954
2018
Q2 		$5.36M Sell
43,200
-52,000
-55% -$6.08M 0.01% 979
2018
Q1 		$10.6M Buy
95,200
+78,300
+463% +$9.36M 0.03% 518
2017
Q4 		$2.02M Sell
16,900
-59,400
-78% -$7.23M 0.01% 1590
2017
Q3 		$10.7M Sell
76,300
-197,100
-72% -$26.8M 0.03% 490
2017
Q2 		$33.3M Buy
+273,400
New +$31.8M 0.12% 154
2017
Q1 		– Sell
-70,300
Closed -$8.6M – 4874
2016
Q4 		$8.6M Buy
70,300
+64,800
+1,178% +$7.93M 0.04% 427
2016
Q3 		$674K Sell
5,500
-7,300
-57% -$940K ﹤0.01% 2439
2016
Q2 		$1.5M Buy
12,800
+200
+2% +$28.4K 0.01% 1548
2016
Q1 		$1.75M Buy
12,600
+5,300
+73% +$778K 0.01% 1307
2015
Q4 		$1.39M Buy
+7,300
New +$1.28M 0.01% 1397
2015
Q3 		– Sell
-2,900
Closed -$524K – 4345
2015
Q2 		$524K Buy
+2,900
New +$500K ﹤0.01% 2241

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Jane Street's ALXN Position: Q3 2021 in Review

Jane Street sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 46,663 shares — an estimated $8.57M sold.

Jane Street first reported a position in ALXN in Q2 2013 and held it in 29 quarters. The position peaked at $24.5M in Q3 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Jane Street reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Jane Street sold 46,663 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8.57M.
  • Jane Street first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 29 quarters.
  • Jane Street's Alexion Pharmaceuticals position peaked at $24.5M in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.